SOLICITATION NOTICE
A -- A SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) FOR SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE I CONTRACT PROPOSALS
- Notice Date
- 8/14/2013
- Notice Type
- Presolicitation
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E128, Rockville, Maryland, 20852, United States
- ZIP Code
- 20852
- Solicitation Number
- PHS-2014-1
- Archive Date
- 12/31/2013
- Point of Contact
- Matthew Portnoy, Ph.D., Phone: 301-435-2688
- E-Mail Address
-
sbir@od.nih.gov
(sbir@od.nih.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- 1. National Institutes of Health, Bethesda, MD 20892 and Centers for Disease Control and Prevention, Atlanta, GA 30305 are soliciting proposals from small business concerns that possess the research and development (R&D) expertise to conduct innovative research that will contribute toward meeting the program objectives of the agencies. A SOLICITATION OF THE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES (DHHS), THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) SMALL BUSINESS INNOVATIVE RESEARCH (SBIR) PROGRAM SOLICITATION PHS 2014-1 with a closing date on or around November 13, 2013, for receipt of proposals, soon will be available electronically through the NIH Small Business Research Funding Opportunities (http://sbir.nih.gov) Web site and at fedbizopps.gov. The SBIR Phase I Contract Solicitation will be available ONLY via electronic means. Printed copies of the Solicitation will not be distributed. Potential offerors are encouraged to check the NIH Small Business Research Funding Opportunities Web site referenced above and fedbizopps.gov for updates on the program. Any updates or corrections to the Solicitation will be posted there. The purposes of the SBIR program are to: (a) stimulate technological innovation in the private sector; (b) strengthen the role of small business in meeting Federal research/research & development (R/R&D) needs; (c) increase the commercial application of Federally-supported research results; (d) foster and encourage participation by socially and economically disadvantaged small business concerns and women-owned business concerns; and improve the return on investment from Federally-funded research for economic and social benefits to the Nation. For purposes of the SBIR program, a small business concern is any business concern that, on the date of award, (1) is organized for profit, with a place of business located in the United States, which operates primarily within the United States or which makes a significant contribution to the United States economy through payment of taxes or use of American products, materials or labor; (2) is in the legal form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust or cooperative, except that where the form is a joint venture, there must be less than 50 percent participation by foreign business entities in the joint venture; (3) more than 50% directly owned and controlled by one or more individuals (who are citizens or permanent resident aliens of the United States), other business concerns (each of which is more than 50% directly owned and controlled by individuals who are citizens or permanent resident aliens of the United States), or any combination of these; OR more than 50% owned by multiple venture capital operating companies, hedge funds, private equity firms, or any combination of these. No single venture capital operating company, hedge fund, or private equity firm may own more than 50% of the concern AND (4) has, including its affiliates, no more than 500 employees. Following are the research topics identified in the NIH/CDC SBIR Contract Solicitation [PHS 2014-1]: NATIONAL INSTITUTES OF HEALTH (NIH) - NATIONAL CANCER INSTITUTE (NCI): Development of Novel Therapeutic Agents that Target Cancer Stem Cells; Reformulation of Failed Chemotherapeutic Drugs; Validation of 3D Human Tissue Culture Systems that Mimic the Tumor Microenvironment; Proteomic Analysis of Single Cells Isolated from Solid Tumors; Generation of Site-Specific Phospho-Threonine Protein Standards for use in Cancer Assays; Development of a Biosensor-Based Core Needle Tumor Biopsy Device; Development of Radiation Modulators for Use During Radiotherapy; Software Tools for the Development of Environmental Measures Related to Cancer Health Behaviors and Resources. NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES (NCATS): Development of Biomarkers for Rare Diseases as Endpoints for Clinical Trial Measurements; Development of Neurocognitive Pediatric Tools for Measuring and Analyzing Clinical Study Endpoints in Rare Neurocognitive Disorders; Exploring the Potential of CRISPR/CAS Genome-editing Tools; Droplet Detection System. NATIONAL HEART, LUNG AND BLOOD INSTITUTE (NHLBI): Passive MRI Cardiovascular Guidewire; MRI Myocardial Needle Injection Catheter; Transcatheter Pulmonary Artery Resist; Value of Information Models for Clinical Trial Assessment; Development of Molecular Imaging Agents and Methods to Detect High Risk Atherosclerotic Plaque; Tools for Educating Children About Clinical Research. NATIONAL INSTITUTE ON AGING (NIA): Development of Calorie-restricted and Nutrient-balanced Medicinal Food Products for Mitigation of Age-related Diseases or Conditions. NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM (NIAAA): Development of a Database of Non-English Measures and Instruments for Use in Alcohol Research. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID): Biomedical Methods To Quantify Adherence To Prevention Clinical Trial Study ¬ Products and Strategies; Simple, Inexpensive Assay for Five Common HIV Resistance Mutations; Capreomycin: Formulation for Oral Delivery; Adjuvant Development. NATIONAL INSTITUTE ON DRUG ABUSE (NIDA): Web Resource System for Prescription Drug Providers, Researchers and Users: The Prescription Drug Abuse Policy System (PDAPS); Technological Tools to Facilitate Implementation of Evidence-Based Substance Abuse Prevention Interventions among the Military; Products to Prevent (Lethal) Drug-induced Respiratory Depression; Bundled Service for Designing Methodologically Rigorous Animal Studies; Affordable Care Act (ACA) Web Platform to Integrate Behavioral Health & Prevention with Primary Care. CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) - CENTER FOR GLOBAL HEALTH (GCH): Development of Novel Malaria Parasite Metabolite-based Non-invasive Diagnostic Biosensor. NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES (NCBDDD): Developing Rapid Test for the Diagnosis of Sickle Cell Disease; Development of Rapid, Point-of-care Tests for Cytomegalovirus (CMV); Nutrition Support for Group Homes Serving Individuals with Intellectual Disabilities. NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION (NCCDPHP): Promoting Regular Physical Activity for Older Adults through "Wayfinding" Technology; Development of Pills or Tablets to Expedite Water Fluoridation; Application for Improving Embryo Transfer Practices at Fertility Clinics. NATIONAL CENTER FOR EMERGING ZOONOTIC AND INFECTIOUS DISEASES (NCEZID): Distinguishing Infection, Colonization, and Recurrence in Patients with Clostridium difficile; Development of Reagents for Diagnosis of Fungal Infections in Formalin-fixed Paraffinized (FFPE) Tissue Blocks; Rapid Detection of Endemic Fungal Infections in the United States; Development of Anti-Japanese Encephalitis Virus Human Monoclonal Antibodies Using Humanized Rodent Models; Formulation of Nootkatone in Soaps and Lotions for Lyme Disease Prevention. NATIONAL CENTER FOR HIV/AIDs, VIRAL HEPATITIS, STD, AND TB PREVENTION (NCHHSTP): Development of a Rapid Test for Detection Hepatitis C Core Antigen in Clinical Samples; Development of a Laboratory Test for Detection of Serum Biomarkers Associated with Hepatocellular Carcinoma; Text My EOB: The Innovative Delivery of Confidential Medical Information; Development of a Mobile Application for Homeless Youth and Providers; Leveraging Technology to Prevent STIs Using High-Intensity Behavioral Counseling; Assessing the Feasibility of e-measure Adoption in an EHR Environment. NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES (NCIRD): Thermostable Dry Vaccine Formulation for Microneedle Administration; Development of Anti-diphtheria Antibodies for Use in Humans. OFFICE OF PUBLIC HEALTH PREPAREDNESS AND RESPONSE (OPHPR): "Plug and Play" Global Health Security Initiative (GHSI) Response Tool; Improved Rapid Antimicrobial Susceptibility Testing from Primary Specimens. 2. NIH/CDC SBIR Contract Solicitation PHS 2014-1, including proposal forms, will be available electronically on/around August 29, 2013 through the NIH Small Business Research Funding Opportunities Web site and at fedbizopps.gov. (Note: The PHS 2013-2 Omnibus Solicitation of the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, and Administration for Children and Families for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) GRANT Applications, where investigator-initiated ideas are encouraged, is still open and is available at the same Web site noted above with a remaining due date of December 5, 2013.) To understand better the differences between grants and contracts, see Contracts vs. Grants: What's the difference? (http://grants.nih.gov/grants/funding/contracts_vs_grants.htm) LINKURL: http://grants.nih.gov/grants/funding/sbir.htm LINKDESC: National Institutes of Health Small Business (SBIR/STTR) Research Funding Opportunities. E-mail: sbir@od.nih.gov
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/PHS-2014-1/listing.html)
- Place of Performance
- Address: Various Locations, United States
- Record
- SN03148189-W 20130816/130814234856-9c2c106a6fe656f3ded5e065512459a8 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |